Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody

In stock
Only %1 left
SKU
ICH1211
Add to Compare
$315.00 - $2,016.00

Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE and HPLC
Species Reactivity
Mouse
Target
PD-1
Concentration
1.0 - 5.0 mg/ml
Isotype
Mouse IgG2a
Host
Mouse
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes
Western Blotting: To detect Mouse PD-1 this antibody can be used at a concentration of 30 µg/ml. Blocking: The 29F.1A12 antibody has been shown to block the binding of PD-1 to its ligands in vivo. For immune checkpoint antibodies 200 ug per mouse per injection is the standard dosage in the literature. NOTE: The response is model dependent. We have seen some tumor lines in mice that grow progressively. If we treat the animal with anti-PD-1 (days 3,6,9 @ 200 ug per animal per injection) then the tumor will regress, and disappear. Each investigator should determine their own optimal working dilution for specific applications.
Applications
Flow Cytometry, Western Blot, Blocking, IHC (Frozen)
Storage
Anti-PD-1 In Vivo Antibody - Low Endotoxin (29F.1A12) is stable when stored at 2-8°C for at least four (4) weeks. For long-term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Formulation
0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added.
Purification Method
This monoclonal antibody was purified using Protein A
Specificity
Anti-PD-1 In Vivo Antibody - Low Endotoxin (29F.1A12) recognizes an epitope on Mouse PD-1. Despite its predicted molecular weight, PD-1 often migrates at higher molecular weight in SDS-PAGE.
Shipping Conditions
Blue ice
Background
PD-1 is an inhibitory checkpoint receptor on activated T cells that limits immune responses and is a cornerstone target of cancer immunotherapy research. Clone 29F.1A12 is a recombinant mouse IgG2a monoclonal antibody recognising mouse PD-1, validated for flow cytometry, Western blot, blocking, and frozen IHC. Anti-PD-1 29F.1A12 is supplied in a low-endotoxin format suitable for in vivo use and is manufactured in scalable milligram to gram quantities for bulk and high-throughput laboratories. As a non-therapeutic, research-use-only reagent, it offers consistent lot-to-lot reproducibility for mouse checkpoint-blockade studies.
Other Names
Programmed cell death protein 1, Pdcd1, CD279
Clone
29F.1A12
Uniprot
Q02242
Buffer
ICH3001-100ml ICH3002-100ml ICH3003-100ml
Antigen Distribution
Induced on splenic T and B lymphocytes, thymocytes, and myeloid cells after stimulation.Subset of double negative thymocytes, activated T and B cells
Immunogen
PD-1 cDNA followed by PD-1-Ig fusion protein
Aggregation
Aggregation level ≤ 5%
Write Your Own Review
You're reviewing:Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody
Your Rating
Back to Top